no code implementations • 27 Feb 2024 • Deqian Kong, Yuhao Huang, Jianwen Xie, Edouardo Honig, Ming Xu, Shuanghong Xue, Pei Lin, Sanping Zhou, Sheng Zhong, Nanning Zheng, Ying Nian Wu
Designing molecules with desirable properties, such as drug-likeliness and high binding affinities towards protein targets, is a challenging problem.
